Patents by Inventor Matthew Manning
Matthew Manning has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240124308Abstract: A compound represented by one of the formulae: BaaMobOc??(1), MOdPeOf??(2) or BagMohPiOj??(3) wherein for formula (1) the ratio of a:b is from 1:100 to 100:1, wherein for formula (2) the ratio of d:e is from 1:100 to less than 1:1 or from greater than 1:1 to 100:1, wherein for formula (3) the ratio of g:h is from 1:100 to less than 1.5:1, wherein for formula (3) the ratio of g:i is from 1:100 to 100:1, wherein for formula (3) the ratio of h:i is from 1:100 to less than 1:2, or from greater than 1:2 to less than 2:1, or from greater than 2:1 to 100:1, and wherein the molybdenum present within the compound is in the 5+ oxidation state.Type: ApplicationFiled: October 12, 2023Publication date: April 18, 2024Inventors: Kevin Sanderson, Anna Colley, John Hodgkinson, David Strickler, Lila Dahal, Vikash Ranjan, Matthew Rosseinsky, Matthew Dyer, Dihao Zeng, Guopeng Han, Jonathon Alaria, Troy Manning, Thomas Beesley, Anna Krowitz
-
Publication number: 20240124351Abstract: A compound represented by one of the formulae: BaaMobOc??(1), MOdPeOf??(2) or BagMohPiOj??(3) wherein for formula (1) the ratio of a:b is greater than 1:1, wherein for formula (2) the ratio of d:e is from 1:100 to 0.45:1 or from 0.55:1 to 100:1, wherein for formula (3) the ratio of g:h is from 1:7 to 1:2 and the ratio of g:i is from 1:3 to 1:1, or the ratio of g:h is from 0.6:1 to 100:1 and the ratio of g:i is from 2.2:1 to 100:1, and wherein the molybdenum present within the compound is in the 4+ oxidation state.Type: ApplicationFiled: October 12, 2023Publication date: April 18, 2024Inventors: Kevin Sanderson, Anna Colley, John Hodgkinson, David Strickler, Lila Dahal, Vikash Ranjan, Matthew Rosseinsky, Dihao Zeng, Matthew Dyer, Guopeng Han, Jonathon Alaria, Troy Manning, Thomas Beesley, Anna Krowitz
-
Patent number: 11947569Abstract: Systems and methods are provided for investigation network activities. Network activity information may be accessed. The network activity information may describe for an individual (1) respective relationship with one or more persons; and (2) respective activity status information indicating whether a given person has engaged in a particular activity. A network activity graph may be generated based on the network activity information. The network activity graph may include two or more nodes representing the individual and the one or more persons. Connections between the nodes may represent the respective relationships between the individual and the one or more persons. Data corresponding to the network activity graph may be presented through an interface.Type: GrantFiled: August 21, 2022Date of Patent: April 2, 2024Assignee: Palantir Technologies Inc.Inventors: Benjamin Funk, Christian Burchhardt, Jakob Juelich, Lawrence Manning, Matthew Elkherj
-
Patent number: 11891879Abstract: A downhole valve, such as a safety valve or sub-sea safety valve (SSSV). The downhole valve comprising: a housing; a flow path between a valve inlet and a valve outlet; a valve mechanism; and a piston member; wherein the valve mechanism is operable by actuation of the piston member to selectively open and close the flow path between the valve inlet and valve outlet; and the piston member is actuatable by a pressure differential between an annulus pressure at the valve and a pressure at the valve outlet and/or in a portion of the flow path closest to the valve outlet. The valve can comprise an opening for receiving the annular pressure that is isolated from the valve inlet and valve outlet. The downhole valve can be configured such that it prevents operation of the valve mechanism to open and/or close the flow path by a pressure differential between the valve inlet and valve outlet.Type: GrantFiled: January 24, 2020Date of Patent: February 6, 2024Assignee: PRAGMA WELL TECHNOLOGY LIMITEDInventor: Matthew Manning
-
Patent number: 11879312Abstract: A screen assembly, such as a downhole/sand screen assembly, comprising first and second screen portions or screens longitudinally coupled together, wherein there is provided a fluid flow path between the first and second screen portions or screen. Optionally, the first and second sleeves are coupled or connected by a centraliser or further sleeve or screen, and/or optionally by or via first and second support ring.Type: GrantFiled: August 25, 2021Date of Patent: January 23, 2024Assignee: WEATHERFORD U.K. LIMITEDInventors: Stephen Reid, Andrew McGeoch, Matthew Manning, Daniel George Purkis
-
Publication number: 20230365669Abstract: Disclosed are methods for treating a patient suffering from osteogenesis imperfecta comprising administering to the patient a therapeutically effective amount of an anti-sclerostin antibody. Methods for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient by administering to the patient a therapeutically effective amount of an anti-sclerostin antibody are also disclosed. Further disclosed are compositions for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient. The compositions comprise a therapeutically effective amount of an anti-sclerostin antibody. The invention also provides an anti-sclerostin antibody for use in the treatment of osteogenesis imperfecta.Type: ApplicationFiled: April 7, 2023Publication date: November 16, 2023Applicant: MEREO BIOPHARMA 3 LIMITEDInventors: Uwe JUNKER, Michaela KNEISSEL, Anthony Kent HALL, Rena Joy EUDY, Matthew Manning RIGGS
-
Publication number: 20230051577Abstract: A valve apparatus comprises a valve body defining a flow path therethrough, a valve member mounted within the valve body, and an actuator assembly mounted internally within the valve body. The actuator assembly comprises a piston bore and piston member defining a piston chamber therebetween, wherein at least one of the piston bore and piston member is engaged or associated with the valve member such that the valve member is moveable in accordance with fluid pressure within the piston chamber to selectively occlude the flow path.Type: ApplicationFiled: February 5, 2021Publication date: February 16, 2023Applicant: Unity Well Integrity LimitedInventors: Matthew MANNING, Jason DUTHIE
-
Publication number: 20220090467Abstract: A downhole valve, such as a safety valve or sub-sea safety valve (SSSV). The downhole valve comprising: a housing; a flow path between a valve inlet and a valve outlet; a valve mechanism; and a piston member; wherein the valve mechanism is operable by actuation of the piston member to selectively open and close the flow path between the valve inlet and valve outlet; and the piston member is actuatable by a pressure differential between an annulus pressure at the valve and a pressure at the valve outlet and/or in a portion of the flow path closest to the valve outlet. The valve can comprise an opening for receiving the annular pressure that is isolated from the valve inlet and valve outlet. The downhole valve can be configured such that it prevents operation of the valve mechanism to open and/or close the flow path by a pressure differential between the valve inlet and valve outlet.Type: ApplicationFiled: January 24, 2020Publication date: March 24, 2022Inventor: Matthew Manning
-
Publication number: 20210381346Abstract: A screen assembly, such as a downhole/sand screen assembly, comprising first and second screen portions or screens longitudinally coupled together, wherein there is provided a fluid flow path between the first and second screen portions or screen. Optionally, the first and second sleeves are coupled or connected by a centraliser or further sleeve or screen, and/or optionally by or via first and second support ring.Type: ApplicationFiled: August 25, 2021Publication date: December 9, 2021Inventors: Stephen Reid, Andrew McGeoch, Matthew Manning, Daniel George Purkis
-
Publication number: 20210253684Abstract: Disclosed are methods for treating a patient suffering from osteogenesis imperfecta comprising administering to the patient a therapeutically effective amount of an anti-sclerostin antibody. Methods for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient by administering to the patient a therapeutically effective amount of an anti-sclerostin antibody are also disclosed. Further disclosed are compositions for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient. The compositions comprise a therapeutically effective amount of an anti-sclerostin antibody. The invention also provides an anti-sclerostin antibody for use in the treatment of osteogenesis imperfecta.Type: ApplicationFiled: December 30, 2020Publication date: August 19, 2021Applicant: MEREO BIOPHARMA 3 LIMITEDInventors: Uwe JUNKER, Michaela KNEISSEL, Anthony Kent HALL, Rena Joy EUDY, Matthew MANNING RIGGS
-
Publication number: 20210253687Abstract: Disclosed are methods for treating a patient suffering from osteogenesis imperfecta comprising administering to the patient a therapeutically effective amount of an anti-sclerostin antibody. Methods for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient by administering to the patient a therapeutically effective amount of an anti-sclerostin antibody are also disclosed. Further disclosed are compositions for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient. The compositions comprise a therapeutically effective amount of an anti-sclerostin antibody. The invention also provides an anti-sclerostin antibody for use in the treatment of osteogenesis imperfecta.Type: ApplicationFiled: February 26, 2021Publication date: August 19, 2021Inventors: Uwe JUNKER, Michaela KNEISSEL, Anthony Kent HALL, Rena Joy EUDY, Matthew Manning RIGGS
-
Patent number: 10961305Abstract: Disclosed are methods for treating a patient suffering from osteogenesis imperfecta comprising administering to the patient a therapeutically effective amount of an anti-sclerostin antibody. Methods for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient by administering to the patient a therapeutically effective amount of an anti-sclerostin antibody are also disclosed. Further disclosed are compositions for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient. The compositions comprise a therapeutically effective amount of an anti-sclerostin antibody. The invention also provides an anti-sclerostin antibody for use in the treatment of osteogenesis imperfecta.Type: GrantFiled: December 21, 2017Date of Patent: March 30, 2021Assignee: MEREO BIOPHARMA 3 LIMITEDInventors: Uwe Junker, Michaela Kneissel, Anthony Kent Hall, Rena Joy Eudy, Matthew Manning Riggs
-
Patent number: 10890053Abstract: A screen assembly, such as a downhole/sand screen assembly, comprising first and second screen portions or screens longitudinally coupled together, wherein there is provided a fluid flow path between the first and second screen portions or screen. Optionally, the first and second sleeves are coupled or connected by a centralizer or further sleeve or screen, and/or optionally by or via first and second support ring.Type: GrantFiled: July 16, 2018Date of Patent: January 12, 2021Assignee: WEATHERFORD U.K. LIMITEDInventors: Stephen Reid, Andrew McGeoch, Matthew Manning, Daniel George Purkis
-
Patent number: 10883343Abstract: A screen assembly, such as a downhole/sand screen assembly, comprising first and second screen portions or screens longitudinally coupled together, wherein there is provided a fluid flow path between the first and second screen portions or screen. Optionally, the first and second sleeves are coupled or connected by a centralizer or further sleeve or screen, and/or optionally by or via first and second support ring.Type: GrantFiled: January 3, 2019Date of Patent: January 5, 2021Assignee: WEATHERFORD U.K. LIMITEDInventors: Stephen Reid, Andrew McGeoch, Matthew Manning, Daniel George Purkis
-
Patent number: 10832747Abstract: A method in a clocked integrated circuit receiving an input clock signal having a clock frequency and a command signal for accessing a memory element in the clocked integrated circuit. The method detects the input clock signal having a clock frequency above or below a frequency threshold. The method generates a clock detect output signal having a first logical state in response to the clock frequency being below the frequency threshold and generates the clock detect output signal having a second logical state in response to the clock frequency being above the frequency threshold. The method delays the command signal by a first timing latency to generate a timing adjusted control signal where the first timing latency is one or more clock periods of the input clock signal. Finally, the method adjusts the first timing latency in response to the clock detect output signal.Type: GrantFiled: January 29, 2019Date of Patent: November 10, 2020Assignee: Integrated Silicon Solution, Inc.Inventors: Steven Eaton, Matthew Manning
-
Publication number: 20200179509Abstract: Disclosed are methods for treating a patient suffering from osteogenesis imperfecta comprising administering to the patient a therapeutically effective amount of an anti-sclerostin antibody. Methods for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient by administering to the patient a therapeutically effective amount of an anti-sclerostin antibody are also disclosed. Further disclosed are compositions for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient. The compositions comprise a therapeutically effective amount of an anti-sclerostin antibody. The invention also provides an anti-sclerostin antibody for use in the treatment of osteogenesis imperfecta.Type: ApplicationFiled: December 21, 2017Publication date: June 11, 2020Applicant: MEREO BIOPHARMA 3 LIMITEDInventors: Uwe JUNKER, Michaela KNEISSEL, Anthony Kent HALL, Rena Joy EUDY, Matthew MANNING RIGGS
-
Publication number: 20200123242Abstract: Disclosed are methods for treating a patient suffering from osteogenesis imperfecta comprising administering to the patient a therapeutically effective amount of an anti-sclerostin antibody. Methods for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient by administering to the patient a therapeutically effective amount of an anti-sclerostin antibody are also disclosed. Further disclosed are compositions for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient. The compositions comprise a therapeutically effective amount of an anti-sclerostin antibody. The invention also provides an anti-sclerostin antibody for use in the treatment of osteogenesis imperfecta.Type: ApplicationFiled: January 2, 2020Publication date: April 23, 2020Applicant: MEREO BIOPHARMA 3 LIMITEDInventors: Uwe JUNKER, Michaela KNEISSEL, Anthony Kent HALL, Rena Joy EUDY, Matthew MANNING RIGGS
-
Publication number: 20190330322Abstract: Disclosed are methods for treating a patient suffering from osteogenesis imperfecta comprising administering to the patient a therapeutically effective amount of an anti-sclerostin antibody. Methods for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient by administering to the patient a therapeutically effective amount of an anti-sclerostin antibody are also disclosed. Further disclosed are compositions for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient. The compositions comprise a therapeutically effective amount of an anti-sclerostin antibody. The invention also provides an anti-sclerostin antibody for use in the treatment of osteogenesis imperfecta.Type: ApplicationFiled: December 21, 2017Publication date: October 31, 2019Applicant: MEREO BIOPHARMA 3 LIMITEDInventors: Uwe JUNKER, Michaela KNEISSEL, Anthony Kent HALL, Rena Joy EUDY, Matthew Manning RIGGS
-
Publication number: 20190172511Abstract: A method in a clocked integrated circuit receiving an input clock signal having a clock frequency and a command signal for accessing a memory element in the clocked integrated circuit. The method detects the input clock signal having a clock frequency above or below a frequency threshold. The method generates a clock detect output signal having a first logical state in response to the clock frequency being below the frequency threshold and generates the clock detect output signal having a second logical state in response to the clock frequency being above the frequency threshold. The method delays the command signal by a first timing latency to generate a timing adjusted control signal where the first timing latency is one or more clock periods of the input clock signal. Finally, the method adjusts the first timing latency in response to the clock detect output signal.Type: ApplicationFiled: January 29, 2019Publication date: June 6, 2019Inventors: Steven Eaton, Matthew Manning
-
Publication number: 20190136672Abstract: A screen assembly, such as a downhole/sand screen assembly, comprising first and second screen portions or screens longitudinally coupled together, wherein there is provided a fluid flow path between the first and second screen portions or screen. Optionally, the first and second sleeves are coupled or connected by a centralizer or further sleeve or screen, and/or optionally by or via first and second support ring.Type: ApplicationFiled: January 3, 2019Publication date: May 9, 2019Inventors: Stephen Reid, Andrew McGeoch, Matthew Manning, Daniel George Purkis